CDS Tool Access for Diabetes Mellitus, Type 2

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Kaiser Permanente Center for Health Research, Portland, OR
Diabetes Mellitus, Type 2+1 More
CDS Tool Access - Other
Eligibility
18+
All Sexes
Eligible conditions
Select

Study Summary

This study is evaluating whether providing care team members with clinical decision support tools can improve outcomes for patients with hypertension and diabetes.

See full description

Eligible Conditions

  • Diabetes Mellitus, Type 2
  • Hypertension

Treatment Effectiveness

Study Objectives

This trial is evaluating whether CDS Tool Access will improve 2 primary outcomes and 3 secondary outcomes in patients with Diabetes Mellitus, Type 2. Measurement will happen over the course of 12 months; in secondary analyses, we will do repeated cross-sectional analysis using 6-, 12-, and 18-month data.

Month 12
BMI
HbA1c
LDL
anti-lipid therapy
blood pressure

Trial Safety

Trial Design

2 Treatment Groups

Control Arm
1 of 2
Intervention Arm
1 of 2
Active Control
Experimental Treatment

This trial requires 60 total participants across 2 different treatment groups

This trial involves 2 different treatments. CDS Tool Access is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Intervention Arm
Other
Intervention clinics will have the CDS tools turned on in their EHR.
Control ArmControl clinics will not receive an intervention.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months; in secondary analyses, we will do repeated cross-sectional analysis using 6-, 12-, and 18-month data
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 12 months; in secondary analyses, we will do repeated cross-sectional analysis using 6-, 12-, and 18-month data for reporting.

Closest Location

Kaiser Permanente Center for Health Research - Portland, OR

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
The clinic has screened over 200 people for social risks in the last 12 months. show original
for adults and children The clinic provides primary care for adults and children show original

Patient Q&A Section

What is diabetes mellitus, type 2?

"Diabetes is a serious illness that contributes to health problems in an individual and their family. Approximately one-third of Canadians older than 15 years have [type 2 diabetes](https://www.withpower.com/clinical-trials/type-2-diabetes) and it causes a significant increase in the risk of cardiovascular disease and death.\n" - Anonymous Online Contributor

Unverified Answer

How many people get diabetes mellitus, type 2 a year in the United States?

"The incidence of diabetes mellitus, type 2, increased substantially in the period between 1976 and 1999, for both whites and blacks. The proportion of whites and blacks diagnosed with diabetes fell. [About] 90% of the whites and blacks had access to medical care. There were major racial differences in the proportion of whites and blacks receiving primary preventive care, but the proportion of blacks and whites receiving secondary preventive intervention, such as blood pressure checks and lipid treatment, did not vary by race." - Anonymous Online Contributor

Unverified Answer

What are the signs of diabetes mellitus, type 2?

"Signs can be mistaken for symptoms. The health care doctor should be aware of certain signs that can be found in individuals with diabetes mellitus, type 2. Diabetes mellitus, type 2 can be managed through a healthy diet, regular physical activity, and regular screening for signs and symptoms. Treat patients who have a BMI of greater than or equal to 25 kg/m2 without proper cause." - Anonymous Online Contributor

Unverified Answer

Can diabetes mellitus, type 2 be cured?

"It cannot be cured as currently treated with medications. It depends on the combination of medications and the individual. Further studies are needed to develop a good combination." - Anonymous Online Contributor

Unverified Answer

What causes diabetes mellitus, type 2?

"Obesity and a high-fat diet are thought to increase the risk of developing diabetes mellitus type-2. Furthermore, stress is suspected to be a causal factor. For those at low risk, however, it is not known whether the risk of developing diabetes is increased. Further research needs to be conducted to determine whether the increased risk of type 2 diabetes could be prevented with lifestyle changes." - Anonymous Online Contributor

Unverified Answer

What are common treatments for diabetes mellitus, type 2?

"While the majority of patients for whom therapy was indicated used oral agents, there is no difference in duration of treatment for those who use alternative agents such as metformin and sulfonylureas. As for those with a prior history of heart failure or a history of cardiovascular disease, the superiority of oral agents is not established." - Anonymous Online Contributor

Unverified Answer

What does cds tool access usually treat?

"Cds-tool access was associated with the prescription of drug therapies that could potentially lower insulin requirements. Moreover, access to cds-tool and access to the CDSC might be useful predictors of future clinical outcomes that could improve patient clinical outcomes." - Anonymous Online Contributor

Unverified Answer

Does cds tool access improve quality of life for those with diabetes mellitus, type 2?

"CDS tool access was associated with significantly improved self-reported HRQOL for patients with type 2 diabetes. The tool is widely understood and is readily available, however, there were no changes in clinical outcomes related to treatment changes." - Anonymous Online Contributor

Unverified Answer

How does cds tool access work?

"Results from a recent clinical trial demonstrated how to use the Cds tool on paper sheets and how to integrate the tool function to enable real-time and contextual access for clinical documentation." - Anonymous Online Contributor

Unverified Answer

What is the average age someone gets diabetes mellitus, type 2?

"The average age of onset of diabetes was 51.7 years, which is different from the age of onset of diabetes, type 1, which is most commonly in children ages 5 to 9 years. The age-specific prevalences of diabetes mellitus, type 2, in the U.S. population were 2.6% in women and 3.8% in men, respectively." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in cds tool access for therapeutic use?

"The CDS tool has undergone further development. We found that several areas need attention: Improved development of interfaces to support patients, development of a workflow to improve the user experience, validation of the tool’s use in clinical practice, enhanced guidance for clinicians, and user interface improvements. The tool's use in clinical practice was assessed using usability and patient acceptance instruments, which were designed for that specific use. For example, we used a tool tailored to assist patients with diabetes in assessing their disease severity." - Anonymous Online Contributor

Unverified Answer

How serious can diabetes mellitus, type 2 be?

"Diabetics suffer major complications related to uncontrolled blood sugars; most significantly cardiovascular and neurological: coronary artery disease, peripheral vascular disease and strokes. A total of 29.3% of diabetic patients die from some form of cardiovascular disease. The majority of deaths occur due to uncontrolled blood sugars and other heart conditions. Diabetes mellitus, type 2 affects about 11% of adult Canadians. [Statistics Canada] is collaborating with Diabetes Ontario (DOO) to find data from health authorities throughout the province to analyze current trends and patterns in care for diabetic patients in Ontario. I am working with DOO to help people, in their own communities and in their own families, to understand the risk factors, cause and control for Diabetes mellitus, type 2 in Ontario." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Diabetes Mellitus, Type 2 by sharing your contact details with the study coordinator.